Literature DB >> 14625378

Increased syndecan expression following myocardial infarction indicates a role in cardiac remodeling.

Alexandra Vanessa Finsen1, Per Reidar Woldbaek, Jian Li, Jiaping Wu, Torstein Lyberg, Theis Tønnessen, Geir Christensen.   

Abstract

The purpose of this study was to identify essential genes involved in myocardial growth and remodeling following myocardial infarction (MI). Left ventricular noninfarcted tissues from six mice subjected to MI under general anesthesia and from six sham-operated mice were obtained 1 wk after primary surgery and analyzed by means of cDNA filter arrays. Out of a total of 1,176 genes, 641 were consistently expressed, twenty-three were upregulated and thirteen downregulated. Five genes were only expressed following MI. Syndecan-3, a transmembranous heparan sulfate proteoglycan, was found to be upregulated together with a transcriptional activator of syndecans, Wilms tumor protein 1 (WT-1). Northern blotting demonstrated a significant upregulation of syndecan-1, -2, -3, and -4, WT-1, fibronectin, and basic fibroblast growth factor (FGF) receptor 1. Furthermore, Western blot analysis showed statistically significant increases in protein levels for syndecan-3 and -4. In conclusion, we have identified a subset of genes with increased expression in noninfarcted left ventricular tissue following MI, including syndecans 1-4, WT-1, fibronectin, collagen 6A, and FGF receptor 1. Since the syndecans link the cytoskeleton to the extracellular matrix and function as required coreceptors for FGF, we suggest a role for the syndecans in cardiac remodeling following MI.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14625378     DOI: 10.1152/physiolgenomics.00144.2002

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  11 in total

1.  Increased level of soluble syndecan-1 in serum correlates with myocardial expression in a rat model of myocardial infarction.

Authors:  Juan Lei; Sheng Neng Xue; Wei Wu; Shu Xian Zhou; Yu Ling Zhang; Gui Yi Yuan; Jing Feng Wang
Journal:  Mol Cell Biochem       Date:  2011-08-14       Impact factor: 3.396

Review 2.  The Endothelial Glycocalyx: A Possible Therapeutic Target in Cardiovascular Disorders.

Authors:  Anastasia Milusev; Robert Rieben; Nicoletta Sorvillo
Journal:  Front Cardiovasc Med       Date:  2022-05-13

3.  Syndecan-4: a component of the mechanosensory apparatus of cardiac fibroblasts.

Authors:  Allen M Samarel
Journal:  J Mol Cell Cardiol       Date:  2012-12-21       Impact factor: 5.000

4.  Genome-wide association and pathway analysis of left ventricular function after anthracycline exposure in adults.

Authors:  Quinn S Wells; Olivia J Veatch; Joshua P Fessel; Aron Y Joon; Rebecca T Levinson; Jonathan D Mosley; Elizabeth P Held; Chase S Lindsay; Christian M Shaffer; Peter E Weeke; Andrew M Glazer; Kevin R Bersell; Sara L Van Driest; Jason H Karnes; Marcia A Blair; Lore W Lagrone; Yan R Su; Erica A Bowton; Ziding Feng; Bonnie Ky; Daniel J Lenihan; Michael J Fisch; Joshua C Denny; Dan M Roden
Journal:  Pharmacogenet Genomics       Date:  2017-07       Impact factor: 2.089

5.  Lack of chemokine signaling through CXCR5 causes increased mortality, ventricular dilatation and deranged matrix during cardiac pressure overload.

Authors:  Anne Waehre; Bente Halvorsen; Arne Yndestad; Cathrine Husberg; Ivar Sjaastad; Ståle Nygård; Christen P Dahl; M Shakil Ahmed; Alexandra V Finsen; Henrik Reims; William E Louch; Denise Hilfiker-Kleiner; Leif E Vinge; Borghild Roald; Håvard Attramadal; Martin Lipp; Lars Gullestad; Pål Aukrust; Geir Christensen
Journal:  PLoS One       Date:  2011-04-18       Impact factor: 3.240

6.  Syndecan-4 is essential for development of concentric myocardial hypertrophy via stretch-induced activation of the calcineurin-NFAT pathway.

Authors:  Alexandra V Finsen; Ida G Lunde; Ivar Sjaastad; Even K Østli; Marianne Lyngra; Hilde O Jarstadmarken; Almira Hasic; Ståle Nygård; Sarah A Wilcox-Adelman; Paul F Goetinck; Torstein Lyberg; Biljana Skrbic; Geir Florholmen; Theis Tønnessen; William E Louch; Srdjan Djurovic; Cathrine R Carlson; Geir Christensen
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

7.  Contribution of syndecan-4 genetic variants to hypertension, the TAMRISK study.

Authors:  Tarja Kunnas; Seppo T Nikkari
Journal:  BMC Res Notes       Date:  2014-11-19

8.  The Heparan Sulfate Proteoglycan Glypican-6 Is Upregulated in the Failing Heart, and Regulates Cardiomyocyte Growth through ERK1/2 Signaling.

Authors:  Arne O Melleby; Mari E Strand; Andreas Romaine; Kate M Herum; Biljana Skrbic; Christen P Dahl; Ivar Sjaastad; Arnt E Fiane; Jorge Filmus; Geir Christensen; Ida G Lunde
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

Review 9.  The Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart.

Authors:  Kate M Herum; Ida G Lunde; Andrew D McCulloch; Geir Christensen
Journal:  J Clin Med       Date:  2017-05-19       Impact factor: 4.241

Review 10.  The Non-Fibrillar Side of Fibrosis: Contribution of the Basement Membrane, Proteoglycans, and Glycoproteins to Myocardial Fibrosis.

Authors:  Michael Chute; Preetinder Aujla; Sayantan Jana; Zamaneh Kassiri
Journal:  J Cardiovasc Dev Dis       Date:  2019-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.